SAN ANTONIO, March 17, 2026--bioAffinity Technologies' new patient case study demonstrates the benefit of CyPath Lung in ...

Biodesix (NASDAQ:BDSX) outlined its current commercial focus, growth priorities, and financial milestones during a ...

Imagine you go to the healthcare provider because you have a bad cough, or maybe you fell and hurt your ribs.

The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.

It can be surprising to learn that lung cancer can develop in people who have never smoked. In fact, up to 20% of lung ...

Study to evaluate clinical performance of CyPath® Lung for the early detection of lung cancer in high-risk patientsMurtha Cancer Center Research Program at Uniformed Services University of the Health ...

The robot is designed to help doctors detect lung cancer at earlier stages.

Married at First Sight U.K. and Australia host Mel Schilling revealed that her cancer has spread to her brain and doctors ...

bioAffinity Technologies Inc BIAF shares are trading higher on Tuesday morning. The move follows the release of a new ...

Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.

Health systems can transition from small-scale artificial intelligence pilots to high-speed, validated rollouts that meaningfully improve patient outcomes by maintaining three key guardrails, ...

Pulmonary involvement is highly prevalent in individuals with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), affecting 82.7% of patients with granulomatosis with polyangiitis ...